促炎细胞因子
乙酰化
炎症
NF-κB
转录因子
激活剂(遗传学)
肿瘤坏死因子α
化学
细胞生物学
NFKB1型
生物
生物化学
免疫学
受体
基因
作者
Hongying Yang,Wei Zhang,Heng Pan,Heidi G. Feldser,Elden Lainez,Christine Miller,Stewart Leung,Zhong Zhong,Huizhen Zhao,Sharon Sweitzer,Thomas Considine,Thomas V. Riera,Vipin Suri,Brian H. White,James L. Ellis,George P. Vlasuk,Christine Loh
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2012-09-28
卷期号:7 (9): e46364-e46364
被引量:329
标识
DOI:10.1371/journal.pone.0046364
摘要
Chronic inflammation is a major contributing factor in the pathogenesis of many age-associated diseases. One central protein that regulates inflammation is NF-κB, the activity of which is modulated by post-translational modifications as well as by association with co-activator and co-repressor proteins. SIRT1, an NAD(+)-dependent protein deacetylase, has been shown to suppress NF-κB signaling through deacetylation of the p65 subunit of NF-κB resulting in the reduction of the inflammatory responses mediated by this transcription factor. The role of SIRT1 in the regulation of NF-κB provides the necessary validation for the development of pharmacological strategies for activating SIRT1 as an approach for the development of a new class of anti-inflammatory therapeutics. We report herein the development of a quantitative assay to assess compound effects on acetylated p65 protein in the cell. We demonstrate that small molecule activators of SIRT1 (STACs) enhance deacetylation of cellular p65 protein, which results in the suppression of TNFα-induced NF-κB transcriptional activation and reduction of LPS-stimulated TNFα secretion in a SIRT1-dependent manner. In an acute mouse model of LPS-induced inflammation, the STAC SRTCX1003 decreased the production of the proinflammatory cytokines TNFα and IL-12. Our studies indicate that increasing SIRT1-mediated NF-κB deacetylation using small molecule activating compounds is a novel approach to the development of a new class of therapeutic anti-inflammatory agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI